Four top executives with West Chester, PA-based Synthes Inc. were indicted by the US Attorney for the Eastern District of Pennsylvania on charges that the company improperly engaged in off-label ...

ZURICH (Reuters) - Synthes <SYST.VX> said on Monday it was in takeover talks with Johnson & Johnson <JNJ.N>, after reports the U.S. group is looking to buy the Swiss medical device maker for about $20 ...

Please provide your email address to receive an email when new articles are posted on . Synthes, Inc. announced that it has acquired The Anspach Effort, Inc., a global company in the high-speed ...

The sentencing of three of the four ex-directors of medical device manufacturer Synthes to terms ranging from five to nine months over the unauthorized use of bone cement in spinal surgery clinical ...

PHILADELPHIA -- A Swiss company with major operations in West Chester, Pa., illegally tested its bone cement on about 200 people, three of whom died, according to a 52-count indictment issued Tuesday, ...

TRENTON, N.J. — Healthcare giant Johnson & Johnson said that it will complete its $19.7 billion purchase of Synthes today — a deal J&J hopes will give it a dominant position in the growing orthopedic ...

Now that they've completed their stints in federal prison, four former Synthes executives have been essentially banished from the healthcare industry for their roles in the Norian bone cement scandal ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shares in Synthes, the Swiss surgical products and medical services group, rose on Monday as it confirmed that ...

PARSIPPANY, N.J., July 02, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (PCRX), a leading provider of innovative non-opioid pain management options, today announced that the company has notified ...

ZURICH (Reuters) - Swiss medical device maker Synthes posted a 24 percent rise in net profit to $348.8 million in the first-half of the year as high demand across all regions and product lines boosted ...

TRENTON, N.J. (AP) -- Healthcare giant Johnson & Johnson said Tuesday that it will complete its $19.7 billion purchase of Synthes on Thursday — a deal J&J hopes will give it a dominant position in the ...